Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor a attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations

Molecular and Cellular Biochemistry

Volumn 156, Issue 2, 1996, Pages 135-143

  Boekstegers, Peter ^a   Kainz, Iris ^a   Giehrl, Wolfgang ^a   Peter, Wolfgang ^a   Werdan, Karl ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiomyocytes; High energy phosphates; Inotropic response; TNF

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIBODY; CALCIUM; CARDIAC GLYCOSIDE; CATECHOLAMINE; DEOXYGLUCOSE; FORSKOLIN; ISOPRENALINE; OUABAIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL WALL; CONTROLLED STUDY; ENERGY METABOLISM; HEART MUSCLE CELL; HIGH ENERGY PHOSPHATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOTROPISM; NONHUMAN; RAT;

ANIMALS; CALCIUM; CATECHOLAMINES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSIDES; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; STROPHANTHUS GRATUS;

EID: 0029888041     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00426336     Document Type: Article

References (26)

1. De Meules JE, Pigula FA, Mueller M, Raymond SJ, Gamelli RL: Tumor necrosis factor and cardiac function. J Trauma 32: 686-692, 1992
2. Geng Y, Hansson GK, Holme E: Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 71: 1268-1276, 1992
3. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF: Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad 86: 6753-6757, 1989
4. Gulick T, Pieper SJ, Murphy MA, Lange LG, Schreiner GF: A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of β-adrenergic responses. Circulation 84: 313-321, 1991
5. Reithmann C, Gierschik P, Werdan K, Jacobs KH: Tumor necrosis factor up-regulates Giα and Gβ proteins and adenylyl cyclase responsiveness in rat cardiomyocytes. Europ J Pharmacol 206: 53-60, 1991
6. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Tumor necrosis factor and cardiac function. Science 257: 387-389, 1992
7. Tredget EE, Yu Ym, Zhong S, Burini R Okusawa S, Gelfand JA, Dinarello CA, Young VR, Burke JF: Role of interleukin- 1 and tumor necrosis factor on energy metabolism in rabbits. Am J Physiol 255: E760-E768, 1988
8. Finkel MS, Hoffman RA, Shen L, Oddis CV, Simmons RL, Hattler BG: Interleukin-6 (IL-6) as mediator of stunned myocardium. Am J Cardiol 71: 1231-1232, 1993
9. Hollenberg SM, Cunnion RE, Lawrence M, Kelly JL, Parillo JE: Tumor necrosis factor depresses myocardial cell function: Results using an in vitro assay of myocyte performance. Clin Res 37: 528A, 1989
10. Kumar A, Dimou C, Snell RJ, Hollenberg SM, Cunnion R, Lawrence M, Uretz E, Parrillo JE: Tumor necrosis factor produces depression of myocardial cell contraction in vitro (abstr). Crit Care Med 20: 278, 1993
11. Vincent JL, Bakker J, Marecaux G, Schandene L, Kahn RJ, Dupon E: Administration of Anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101: 810-815, 1992
12. Boekstegers P, Weidenhofer S, Zell R, Pilz G, Holler E, Ertl W, Kapsner T, Redl H, Schlag G, Kaul M, Kempeni J, Stenzel R Werdan K: Repeated administration of a F(ab′)2 fragment of an anti-tumor necrosis factor a monoclonal antibody in patients with severe sepsis: Effects on the cardiovascular system and cytokine levels. Shock 1: 237-245, 1994
13. Lanore JJ, Dhainaut JF, Fisher JC, Opal SM, Zimmerman J, Nightingale P, Stephens S, Schein R1, Panacek EA, Vincent JL, Foulke GE, Warren EL, Gerrard C, Park G, Bodmer MW, Cohen J, Van der Linden C, Sadoff JC, Pochard F and the CB0006 Study Group: Effects of an anti-TNF IgG monoclonal antibody on left ventricular performance in septic patients. Intens Care Med 18: 49 (abstr), 1992
14. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failiure. N Engl J Med 323: 236-241, 1990
15. Maury CPJ, Teppo AM: Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. Int Med 225: 333-336, 1989
16. Latini R, Bianchi M, Correale E, Dinarello CA, Fanzuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Shapiro L, Sironi M, Tognoni G, Turato R, Ghezzi P: Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. Cardiovasc Pharmacol 23: 1-6, 1994
17. Fisher CJ, Opal SM, Dhainaut JF, Stephens S, Zimmermann JL, Nightingale P, Harris SJ, Schein RM, Panacek EA, Vincent JL, Foulke GE, Warren EL, Gerrard C, Park G, Bodmer MW, Cohen J, Van der Linden C, Gross AL, Sadoff JC and the CB0006 sepsis syndrome study group: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21: 318-327, 1993
18. Weisensee D, Bereiter-Hahn J, Schoeppe W, Löw-Friedrich J: Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmac 15: 581-587, 1993
19. Mela-Riker L, Bartos D, Viessis AA, Widener L, Muller P, Trunkey DD: Chronic hyperdynamic sepsis in the rat. II. Characterization of liver and muscle energy metabolism. Circ Shock 36: 83-92, 1992
20. Möller A, Emling F, Blohm D, Schlick E, Schollmeier K: Monoclonal antibodies to human tumor necrosis factor α: in vitro and in vivo application. Cytokine 2: 162-169, 1990
21. Werdan K, Erdmann E: Preparation and culture of embryonic and neonatal heart muscle cells: Modification of transport activity. Meth Enzymol 173: 634-662, 1989
22. Boekstegers P, Pfeiffer A, Peter W, Werdan K: Contractile dysfunction of 'reperfused' neonatal rat heart cells: a model for studying 'myocardial stunning' at the cellular level? Adv Exp Med Biol 317: 573-582, 1992
23. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ: Protein measurement with the folin phenolreagent. J Biol Chem 193: 265-270, 1951
24. Furst W, Hallström S: Simultaneous determination of myocardial nucleosides, purine bases and creatine phosphate by ion-pair high performance liquid chromatography. Chromatography 578: 39-44, 1992
25. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 93: 2303-2312, 1993
26. Schulze-Osthoff K, Bakker AC, Vanhaesebrook B, Beyaert R, Jacob WA, Fiers W: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Biol Chem 267: 5317-5323, 1992